In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway

20250 citationsJournal Article

Authors

MYR mitigates DOX-induced cardiotoxicity through antioxidant and antiinflammatory mechanisms involving inhibition of NF-κB signaling.

Published in: Current Protein and Peptide Science

Volume 26

Field-Weighted Citation Impact: 0.00